首页 | 官方网站   微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   2648194篇
  免费   224841篇
  国内免费   26033篇
医药卫生   2899068篇
  2021年   29685篇
  2020年   21732篇
  2019年   27568篇
  2018年   34925篇
  2017年   28203篇
  2016年   29372篇
  2015年   36880篇
  2014年   50347篇
  2013年   65158篇
  2012年   90028篇
  2011年   96449篇
  2010年   57499篇
  2009年   52340篇
  2008年   84506篇
  2007年   88720篇
  2006年   89795篇
  2005年   87783篇
  2004年   79098篇
  2003年   76015篇
  2002年   73980篇
  2001年   117965篇
  2000年   122971篇
  1999年   105807篇
  1998年   30990篇
  1997年   28860篇
  1996年   27755篇
  1995年   28181篇
  1994年   26080篇
  1993年   23389篇
  1992年   81525篇
  1991年   78275篇
  1990年   75243篇
  1989年   72250篇
  1988年   67019篇
  1987年   65711篇
  1986年   62103篇
  1985年   59042篇
  1984年   44523篇
  1983年   37810篇
  1982年   22970篇
  1979年   41364篇
  1978年   28954篇
  1977年   24303篇
  1976年   22798篇
  1975年   23940篇
  1974年   29653篇
  1973年   28064篇
  1972年   26255篇
  1971年   24172篇
  1970年   22760篇
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
91.
92.
93.

Objective

Comparative survival between neoadjuvant chemotherapy and adjuvant chemotherapy for patients with cT2-4N0-1M0 non–small cell lung cancer has not been extensively studied.

Methods

Patients with cT2-4N0-1M0 non–small cell lung cancer who received platinum-based chemotherapy were retrospectively identified. Exclusion criteria included stage IV disease, induction radiotherapy, and targeted therapy. The primary end point was disease-free survival. Secondary end points were overall survival, chemotherapy tolerance, and ability of Response Evaluation Criteria In Solid Tumors response to predict survival. Survival was estimated using the Kaplan–Meier method, compared using the log-rank test and Cox proportional hazards models, and stratified using matched pairs after propensity score matching.

Results

In total, 330 patients met the inclusion criteria (n = 92/group after propensity-score matching; median follow-up, 42 months). Five-year disease-free survival was 49% (95% confidence interval, 39-61) for neoadjuvant chemotherapy versus 48% (95% confidence interval, 38-61) for adjuvant chemotherapy (P = .70). On multivariable analysis, disease-free survival was not associated with neoadjuvant chemotherapy or adjuvant chemotherapy (hazard ratio, 1.1; 95% confidence interval, 0.64-1.90; P = .737), nor was overall survival (hazard ratio, 1.21; 95% confidence interval, 0.63-2.30; P = .572). The neoadjuvant chemotherapy group was more likely to receive full doses and cycles of chemotherapy (P = .014/0.005) and had fewer grade 3 or greater toxicities (P = .001). Response Evaluation Criteria In Solid Tumors response to neoadjuvant chemotherapy was associated with disease-free survival (P = .035); 15% of patients receiving neoadjuvant chemotherapy (14/92) had a major pathologic response.

Conclusions

Timing of chemotherapy, before or after surgery, is not associated with an improvement in overall or disease-free survival among patients with cT2-4N0-1M0 non–small cell lung cancer who undergo complete surgical resection.  相似文献   
94.
95.
96.
97.
98.
99.
We report a Chinese family with members affected by epidermolytic ichthyosis (EI), caused by KRT gene mutations. The proband was a 14‐year‐old boy who had simultaneous appearance of nephroblastoma and epidermolytic ichthyosis (EI). Both the patient and his mother exhibited the specific clinical and pathological manifestations of EI. We analysed all exons and flanking sequences of the KRT1 and KRT10 genes using PCR, and found that the proband and his mother had a G>C transition at nucleotide position 1432 in exon 7 of KRT1, resulting in an amino acid substitution of glutamate (GAA) to glutamine (CAA) at codon 478 (E478Q). The KRT10 gene had no mutations.  相似文献   
100.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司    京ICP备09084417号-23

京公网安备 11010802026262号